Pharmacokinetics and molecular detoxication.
暂无分享,去创建一个
J R Cashman | J. Cashman | C. Berkman | B. Y. Perotti | B Y Perotti | C E Berkman | J Lin | J. Lin | John R. Cashman | Beatrice Y. T. Perotti | Clifford E. Berkman | Jing Lin | Jing Lin
[1] J. Sommadossi,et al. Modulation of 3'-azido-3'-deoxythymidine catabolism by probenecid and acetaminophen in freshly isolated rat hepatocytes. , 1991, Biochemical pharmacology.
[2] S. Wrighton,et al. In vitro-in vivo correlations of human (S)-nicotine metabolism. , 1995, Biochemical pharmacology.
[3] D. M. Soderlund,et al. Structure-biodegradability relationships in pyrethroid insecticides , 1975, Archives of environmental contamination and toxicology.
[4] A. Varki,et al. A sialic acid-specific O-acetylesterase in human erythrocytes: possible identity with esterase D, the genetic marker of retinoblastomas and Wilson disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Gupta,et al. Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. , 1987, Toxicology.
[6] C. Irving. Influence of the aryl group on the reaction of glucuronides of N-arylacethydroxamic acids with polynucleotides. , 1977, Cancer research.
[7] Y. Hatakeyama,et al. Phenthoate metabolites in human poisoning. , 1994, Journal of toxicology. Clinical toxicology.
[8] David G. Da Vila,et al. The Etiology of Lung Cancer , 1993 .
[9] M. Wayner,et al. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity , 1991, Neuroscience & Biobehavioral Reviews.
[10] M. Jackson,et al. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Brockmöller,et al. Assessment of Liver Metabolic Function , 1994, Clinical pharmacokinetics.
[12] J. Mordenti,et al. Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.
[13] L. Benet,et al. Noncompartmental determination of the steady-state volume of distribution. , 1979, Journal of pharmaceutical sciences.
[14] W. Benedict,et al. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. , 1980, Science.
[15] B. Martin,et al. Cloning and sequencing of a human liver carboxylesterase isoenzyme. , 1991, Life sciences.
[16] K. Wakabayashi,et al. Purification and characterization of esterases D-1 and D-2 from human erythrocytes. , 1988, Archives of biochemistry and biophysics.
[17] H. Willard,et al. Cloning of the esterase D gene: a polymorphic gene probe closely linked to the retinoblastoma locus on chromosome 13. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Radomski,et al. N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicity. , 1979, Toxicology and applied pharmacology.
[19] J. Lewis,et al. Comparative localization of carboxylesterase in F344 rat, Beagle dog, and human nasal tissue , 1994, The Anatomical record.
[20] B B Brodie,et al. Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Luders,et al. Metabolism of tripelennamine in man. , 1976, Drug metabolism and disposition: the biological fate of chemicals.
[22] M. Jackson,et al. Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA. , 1987, The Biochemical journal.
[23] B. Gallie,et al. Re-evaluation of the sublocalization of esterase D and its relation to the retinoblastoma locus by in situ hybridization. , 1987, Cytogenetics and cell genetics.
[24] W. Bosron,et al. Human liver cocaine carboxylesterases. , 1997, NIDA research monograph.
[25] G. Mulder,et al. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate. , 1982, Journal of Pharmacology and Experimental Therapeutics.
[26] E. LaVoie,et al. Short-term studies on the in vivo metabolism of N-oxides of nicotine in rats. , 1986, Journal of toxicology and environmental health.
[27] H. Chapman,et al. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. , 1991, The Journal of biological chemistry.
[28] E. Ralston,et al. Sequence of three bronze alleles of maize and correlation with the genetic fine structure. , 1988, Genetics.
[29] C. King,et al. Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts. , 1976, Biochemical pharmacology.
[30] S. Oka,et al. A novel glucuronyltransferase in nervous system presumably associated with the biosynthesis of HNK-1 carbohydrate epitope on glycoproteins. , 1992, The Journal of biological chemistry.
[31] R. Thurman,et al. The liver plays a central role in the mechanism of chemical carcinogenesis due to polycyclic aromatic hydrocarbons. , 1991, Carcinogenesis.
[32] O. Lockridge,et al. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] F. A. Smith,et al. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.
[34] Baggot Jd. Application of interspecies scaling to the bispyridinium oxime HI-6. , 1994 .
[35] S. Packman,et al. Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus. , 1984, Journal of medical genetics.
[36] W. Mattes,et al. alpha-Naphthyl butyrate carboxylesterase activity in human and rat nasal tissue. , 1992, Toxicology and applied pharmacology.
[37] J R Cashman,et al. Structural and catalytic properties of the mammalian flavin-containing monooxygenase. , 1995, Chemical research in toxicology.
[38] P. Coates,et al. A preliminary genetic interpretation of the esterase isozymes of human tissues , 1975, Annals of human genetics.
[39] U. Bondesson,et al. Analysis of methadone disposition in the pregnant rat by means of a physiological flow model , 1985, Journal of Pharmacokinetics and Biopharmaceutics.
[40] F. Fonnum,et al. Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[41] A. Smolen,et al. PURIFICATION OF HUMAN SERUM PARAOXONASE/ARYLESTERASE , 1991 .
[42] S. D. Murphy,et al. The role of hepatic biotransformation in mediating the acute toxicity of the phosphorothionate insecticide chlorpyrifos. , 1984, Toxicology and applied pharmacology.
[43] D. Hoffmann,et al. Chemical Studies on Tobacco Smoke LXIV. On the Analysis of Aromatic Amines in Cigarette Smoke , 1979 .
[44] S. L. Aukerman,et al. Detoxification of nitrosamides and nitrosocarbamates in blood plasma and tissue homogenates. , 1984, Environmental mutagenesis.
[45] F. Douglas Boudinot,et al. Pharmacokinetics of 2′,3′‐Dideoxycytidine in Rats: Application to Interspecies Scale‐up , 1989, The Journal of pharmacy and pharmacology.
[46] T. Fox,et al. Molecular mechanisms involved in the toxicity of orthophenylphenol and its sodium salt. , 1983, Chemico-biological interactions.
[47] E C Miller,et al. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.
[48] P. Welling,et al. Pharmacokinetics: Regulatory-Industrial-Academic Perspectives , 1988 .
[49] M. McKenna,et al. Hydrolysis of several glycol ether acetates and acrylate esters by nasal mucosal carboxylesterase in vitro. , 1985, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[50] Antonio F. Hernández,et al. Differences in the kinetic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver. , 1994, Biochemical pharmacology.
[51] J. Hearst,et al. Functional expression of zeaxanthin glucosyltransferase from Erwinia herbicola and a proposed uridine diphosphate binding site. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[52] K. Krishnaswamy,et al. Effect of turmeric on xenobiotic metabolising enzymes , 1993, Plant foods for human nutrition.
[53] K. Bock. UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. , 1994, Advances in pharmacology.
[54] R. Lorentzen,et al. Benzo[a]yrenedione/benzo[a]pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. , 1977, Biochemistry.
[55] R. Doll,et al. Etiology of lung cancer. , 1950, Advances in cancer research.
[56] T. Visser,et al. Multiple UDP‐glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3',5'‐triiodothyronine (reverse T3) , 1993, FEBS letters.
[57] J. Yunis,et al. Retinoblastoma and subband deletion of chromosome 13. , 1978, American journal of diseases of children.
[58] R. H. Wilson,et al. The Toxicity and Carcinogenic Activity of 2-Acetaminofluorene , 1941 .
[59] S. Pond,et al. Cloning and analysis of a cDNA encoding a human liver carboxylesterase. , 1991, Gene.
[60] N. Benowitz,et al. Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide. , 1993, Chemical research in toxicology.
[61] J. Chambers,et al. Time course of inhibition of acetylcholinesterase and aliesterases following parathion and paraoxon exposures in rats. , 1990, Toxicology and applied pharmacology.
[62] J. Kuykendall,et al. Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated. , 1993, Toxicology and applied pharmacology.
[63] F. Kadlubar,et al. N-methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[64] K. J. Donham,et al. Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans. , 1980, Drug metabolism and disposition: the biological fate of chemicals.
[65] R. E. Reed,et al. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues. , 1991, Biochemical and biophysical research communications.
[66] B. Burchell,et al. The Uridine Diphosphate Glucuronosyltransferase Multigene Family: Function and Regulation , 1994 .
[67] S. Jezequel. Fluconazole: Interspecies Scaling and Allometric Relationships of Pharmacokinetic Properties , 1994, The Journal of pharmacy and pharmacology.
[68] D. Campbell. Can Allometric Interspecies Scaling be Used to Predict Human Kinetics? , 1994 .
[69] G. Mulder. Conjugation reactions in drug metabolism : an integrated approach : substrates, co-substrates, enzymes and their interactions in vivo and in vitro , 1990 .
[70] T. Lavé,et al. A new extrapolation method from animals to man: application to a metabolized compound, mofarotene. , 1995, Life sciences.
[71] C. R. Kee,et al. Metabolism of dibasic esters by rat nasal mucosal carboxylesterase. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[72] F. Fonnum,et al. Carboxylesterases, Importance for Detoxification of Organophosphorus Anticholinesterases and Trichothecenes , 1985 .
[73] R Snyder,et al. Partial hepatectomy reduces both metabolism and toxicity of benzene. , 1979, Journal of toxicology and environmental health.
[74] N. Benowitz,et al. Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide. , 1992, Chemical research in toxicology.
[75] W. Lee,et al. Purification, biochemical characterization, and biological function of human esterase D. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[76] A. Pandey,et al. Effect of UDP-glucuronyltransferase induction on zearalenone metabolism. , 1990, Toxicology letters.
[77] M. Castle,et al. Species differences in the hydrolysis of meperidine and its inhibition by organophosphate compounds. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[78] A. Smolen,et al. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[79] N. Schiller,et al. Malathion and phenthoate carboxylesterase activities in pulmonary alveolar macrophages as indicators of lung injury. , 1983, Toxicology and applied pharmacology.
[80] P. Magee,et al. Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine. , 1990, Cancer research.
[81] J. Miller,et al. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.
[82] M. Ehrich,et al. DDVP (dichlorvos) detoxification by binding and interactions with DDT, dieldrin, and malaoxon. , 1977, Journal of toxicology and environmental health.
[83] H. Boxenbaum,et al. Physiological Models, Allometry, Neoteny, Space-Time and Pharmacokinetics , 1988 .
[84] D. M. Maxwell,et al. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. , 1987, Toxicology letters.
[85] M. Tsuboi,et al. Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. , 1980, Japanese journal of pharmacology.
[86] H. Boxenbaum,et al. Interspecies pharmacokinetic scaling and the Dedrick plots. , 1983, The American journal of physiology.
[87] C. Green,et al. Effects of soya bean flakes and liquorice root extract on enzyme induction and toxicity in B6C3F1 mice. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[88] S. Mommsen,et al. Tobacco as a risk factor in bladder cancer. , 1983, Carcinogenesis.
[89] W. J. Meek,et al. THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY. , 1938, Science.
[90] J. Miller,et al. Electrophilic sulfuric acid ester metabolites as ultimate carcinogens. , 1986, Advances in experimental medicine and biology.
[91] Z. Radić,et al. Differentiation of esterases reacting with organophosphorus compounds. , 1993, Chemico-biological interactions.
[92] F. Fonnum,et al. Metabolism of T-2 toxin by rat liver carboxylesterase. , 1986, Biochemical pharmacology.
[93] L. Sultatos,et al. The role of calcium in the hydrolysis of the organophosphate paraoxon by human serum A-esterase. , 1995, Life sciences.
[94] E. Heymann,et al. Organophosphate sensitive and insensitive carboxylesterases in human skin. , 1993, Chemico-biological interactions.
[95] T. Ma,et al. Role of detoxication pathways in acute toxicity levels of phosphorothionate insecticides in the rat. , 1994, Life sciences.
[96] P. Bosma,et al. Jaundice and disorders of bilirubin metabolism , 1998 .
[97] T. Omura,et al. Molecular cloning and characterization of a human carboxylesterase gene. , 1993, Genomics.
[98] K. Bischoff,et al. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). , 1970, Cancer chemotherapy reports.
[99] D. Lang,et al. Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds. , 1991, Chemico-biological interactions.
[100] V. Jagadeesan,et al. Effect of long term iron deficiency on the activities of hepatic and extra-hepatic drug metabolising enzymes in Fischer rats. , 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[101] Cornelius Ce. Fasting hyperbilirubinemia in Bolivian squirrel monkeys with a Gilbert's-like syndrome. , 1993 .
[102] G. E. Smith. The Human Brain , 1924, Nature.
[103] B. Burchell,et al. Glucuronidation in fish , 1991 .
[104] W. Bosron,et al. Purification and characterization of a human liver cocaine carboxylesterase that catalyzes the production of benzoylecgonine and the formation of cocaethylene from alcohol and cocaine. , 1994, Biochemical pharmacology.
[105] A. Smolen,et al. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[106] Malcolm Rowland,et al. Clinical pharmacokinetics : concepts and applications , 1989 .
[107] R. Gupta,et al. Concerted role of carboxylesterases in the potentiation of carbofuran toxicity by iso-OMPA pretreatment. , 1989, Journal of toxicology and environmental health.
[108] F. Chu,et al. Modification of in vitro metabolism of T-2 toxin by esterase inhibitors , 1985, Applied and environmental microbiology.
[109] A. Viani,et al. Human Brain Sulphotransferase and Glucuronyltransferase , 1990, Human & experimental toxicology.
[110] Sam. Smoking-attributable mortality and years of potential life lost--United States, 1988. , 1991, MMWR. Morbidity and mortality weekly report.
[111] P. Blain,et al. Human xenobiotic metabolizing esterases in liver and blood. , 1993, Biochemical pharmacology.
[112] J. Crigler,et al. Congenital familial nonhemolytic jaundice with kernicterus. , 1952, Pediatrics.
[113] C. Fenselau,et al. Species-dependent glucuronidation of drugs by immobilized rabbit, rhesus monkey, and human UDP-glucuronyltransferases. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[114] Y. Fujii‐Kuriyama,et al. Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. , 1986, The Journal of biological chemistry.
[115] F. Williams. Clinical Significance of Esterases in Man , 1985, Clinical pharmacokinetics.